Brief: Bliss Gvs Pharma Approves Internal Restructuring Of Foreign Units
16/02/2024 15:27
Feb 16 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS :
* APPROVED AN INTERNAL RESTRUCTURING OF FOREIGN SUBSIDIARIES
OF
COMPANY
Source text for Eikon: ID:nBSE2BQhKM
Further company coverage: BLIS.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees